Cargando…
SUCO as a Promising Diagnostic Biomarker of Hepatocellular Carcinoma: Integrated Analysis and Experimental Validation
BACKGROUND: Hepatocellular carcinoma (HCC) is not frequently diagnosed until the late stage due to its concealed symptoms. Therefore, the identification of biomarkers that have effective diagnostic performance and act as potential key therapeutic targets for HCC becomes urgent. MATERIAL/METHODS: Com...
Autores principales: | Yue, Chaosen, Liang, Chaojie, Ge, Hua, Yan, Lijun, Xu, Yingchen, Li, Guangming, Wu, Jixiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716297/ https://www.ncbi.nlm.nih.gov/pubmed/31434866 http://dx.doi.org/10.12659/MSM.915262 |
Ejemplares similares
-
Identification of Potential Diagnostic and Prognostic Pseudogenes in Hepatocellular Carcinoma Based on Pseudogene-miRNA-mRNA Competitive Network
por: Yan, Lijun, et al.
Publicado: (2020) -
Pseudogene DUXAP10 acts as a diagnostic and prognostic marker and promotes cell proliferation by activating PI3K/AKT pathway in hepatocellular carcinoma
por: Yue, Chaosen, et al.
Publicado: (2019) -
Comprehensive analysis of potential prognostic genes for the construction of a competing endogenous RNA regulatory network in hepatocellular carcinoma
por: Yue, Chaosen, et al.
Publicado: (2019) -
DUXAP8 a Pan-Cancer Prognostic Marker Involved in the Molecular Regulatory Mechanism in Hepatocellular Carcinoma: A Comprehensive Study Based on Data Mining, Bioinformatics, and in vitro Validation
por: Yue, Chaosen, et al.
Publicado: (2019) -
Prognostic Value and Molecular Regulatory Mechanism of MSTO2P in Hepatocellular Carcinoma: A Comprehensive Study Based on Bioinformatics, Clinical Analysis and in vitro Validation
por: Yan, Lijun, et al.
Publicado: (2020)